Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors

Since patients with medullary thyroid cancer (MTC) often have metastatic disease at the time of diagnosis, the development of efficient systemic treatment options for MTC is important. Vandetanib and cabozantinib are two tyrosine kinase inhibitors (TKIs) that were recently approved by FDA and EMA fo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Sandblom, Viktor, Spetz, Johan, Shubbar, Emman, Montelius, Mikael, Ståhl, Ingun, Swanpalmer, John, Nilsson, Ola, Forssell-Aronsson, Eva
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252631/
https://ncbi.nlm.nih.gov/pubmed/32459817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233720
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller